Toward a Better Understanding of the Physical Stability of Amorphous Anti-Inflammatory Agents: The Roles of Molecular Mobility and Molecular Interaction Patterns

Mol Pharm. 2015 Oct 5;12(10):3628-38. doi: 10.1021/acs.molpharmaceut.5b00351. Epub 2015 Sep 8.

Abstract

The aim of this article is to examine the crystallization tendencies of three chemically related amorphous anti-inflammatory agents, etoricoxib, celecoxib, and rofecoxib. Since the molecular mobility is considered as one of the factors affecting the crystallization behavior of a given material, broadband dielectric spectroscopy was used to gain insight into the molecular dynamics of the selected active pharmaceutical ingredients. Interestingly, our experiments did not reveal any significant differences in their relaxation behavior either in the supercooled liquid or in the glassy state. Hence, as a possible explanation for the enhanced physical stability of etoricoxib, its ability to undergo a tautomerization reaction was recognized. The occurrence of intramolecular proton transfer in the disordered etoricoxib was proven experimentally by time-dependent dielectric and infrared (IR) measurements. Additionally, IR spectroscopy combined with density functional theory calculations pointed out that in the etoricoxib drug, being in fact a binary mixture of tautomers, the individual isomers may interact with each other through a hydrogen bonding network. A possible explanation of this issue was achieved by performing dielectric experiments at elevated pressure. Since compression results in etoricoxib recrystallization, the possible influence of pressure on the observed stabilization effect is also carefully discussed.

Keywords: amorphous drug; hydrogen bonding; molecular dynamics; molecular interactions; physical stability; tautomerization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / chemistry*
  • Celecoxib / chemistry*
  • Crystallization
  • Dielectric Spectroscopy
  • Drug Stability*
  • Etoricoxib
  • Lactones / chemistry*
  • Pyridines / chemistry*
  • Sulfones / chemistry*

Substances

  • Anti-Inflammatory Agents
  • Lactones
  • Pyridines
  • Sulfones
  • rofecoxib
  • Celecoxib
  • Etoricoxib